| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000030508 |
| Receipt No. | R000032637 |
| Official scientific title of the study | Evaluation of anterior segment image analysis using Swept Source OCT |
| Date of disclosure of the study information | 2017/12/22 |
| Last modified on | 2019/01/17 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Evaluation of anterior segment image analysis using Swept Source OCT | |
| Title of the study (Brief title) | Evaluation of anterior segment analysis using SS OCT | |
| Region |
|
|
| Condition | ||
| Condition | glaucoma, corneal dystrophy, leucoma, corneal degeneration, corneal irregular astigmatism, bullous keratopathy, keratoconus, lens disease, post corneal transplantation | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy of anterior segment image analysis using Swept Source OCT PLEX elite 9000 (manufactured by Carl Zeiss Meditech), which attached unapproved anterior segment attachment |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | To evaluate the number of taking anterior segment images by using Swept Source OCT and Cirrus 4000 HD-OCT for Anterior chamber depth, Angle opening degree, and Corneal thickness |
| Key secondary outcomes | correlation with OCT image, visual acuity, intraocular pressure, and Fundus findings |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Analyzing images acquired using Swept Source OCT and Cirrus 4000 HD-OCT when the cases are enrolled and images acquired as needed during fifty two weeks from the enrollment of this study | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Those who are visiting or hospitalized at Ophthalmology Department of Shiga Medical University Hospital during this research period
2)Those who have an abnormality in the anterior ocular segment such as cornea, angle, iris 3)Those who can obtain agreement to research participation |
|||
| Key exclusion criteria | 1)Those who might induce epileptic seizures by light stimulation
2)Those who receive photodynamic therapy within forty eight hours |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Takamasa Mori |
| Organization | Shiga University of Medical Science |
| Division name | department of opthalmology |
| Address | Seta-Tsukinowacho, Otsu, Shiga, Japan |
| TEL | 077-548-2276 |
| mrtkms23@belle.shiga-med.ac.jp | |
| Public contact | |
| Name of contact person | Takamasa Mori |
| Organization | Shiga University of Medical Science |
| Division name | department of opthalmology |
| Address | Seta-Tsukinowacho, Otsu, Shiga, Japan |
| TEL | 077-548-2276 |
| Homepage URL | |
| mrtkms23@belle.shiga-med.ac.jp | |
| Sponsor | |
| Institute | Shiga University of Medical Science |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Carl Zeiss Meditec, Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 滋賀医科大学医学部付属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000032637 |